MEDICALNeurologyHealth Calculator
๐Ÿ’Š

Gabapentin Dosing

Gabapentin (Neurontin) is a GABA analog for neuropathic pain and seizures. Dosing requires renal adjustment, gradual titration, and awareness of opioid interaction risks.

Did our AI summary help? Let us know.

FDA boxed warning: respiratory depression with opioids Renal dose adjustment required Taper to discontinue

Ready to run the numbers?

Why: Proper gabapentin dosing prevents under-treatment of pain and avoids toxicity. Renal impairment, opioid use, and respiratory conditions require dose adjustment.

How: Target doses vary by indication. Start 300mg QHS, titrate over weeks. CrCl-based adjustments apply. Bioavailability decreases at higher doses.

FDA boxed warning: respiratory depression with opioidsRenal dose adjustment required
Sources:FDA Lexicomp

Run the calculator when you are ready.

Calculate Gabapentin DoseUse the calculator below to check your health metrics

๐Ÿฆถ Diabetic Peripheral Neuropathy

New patient with moderate diabetic nerve pain, normal renal function

Click to load

โšก Postherpetic Neuralgia

Elderly patient with severe shingles-related nerve pain

Click to load

๐Ÿง  Adjunctive Seizure Therapy

Add-on therapy for partial seizures in adult

Click to load

๐Ÿฉบ CKD Stage 4 Patient

Neuropathic pain with severe renal impairment requiring dose adjustment

Click to load

โš ๏ธ Concurrent Opioid Use

Patient on chronic opioids requiring gabapentin - FDA warning applies

Click to load

Clinical Scenarios

๐Ÿฆถ Diabetic Peripheral Neuropathy

Neuropathic Pain

New patient with moderate diabetic nerve pain, normal renal function

โšก Postherpetic Neuralgia

Neuropathic Pain

Elderly patient with severe shingles-related nerve pain

๐Ÿง  Adjunctive Seizure Therapy

Epilepsy

Add-on therapy for partial seizures in adult

๐Ÿฉบ CKD Stage 4 Patient

Renal Adjustment

Neuropathic pain with severe renal impairment requiring dose adjustment

โš ๏ธ Concurrent Opioid Use

High Risk

Patient on chronic opioids requiring gabapentin - FDA warning applies

Patient
Dosing
Renal
Safety

Gabapentin Dosing Results

Risk Level: Low

Target Dose

1800mg

TID

Single Dose

600mg

per administration

Titration

4wk

28 days

Safety

Standard

Titration Schedule

TimepointMorningAfternoonEveningTotalNotes
Day 1--300300mgDay 1: Evening only
Day 2300-300600mgDay 2: BID
Day 3300300300900mgDay 3+: TID
Week 24004004001200mgWeek 2: Increase if tolerated
Week 35005005001500mgWeek 3: Increase if tolerated
Week 46006006001800mgWeek 4: Increase if tolerated

๐Ÿ›‘ Discontinuation Guidance

  • โš ๏ธ Do NOT stop abruptly - taper over minimum 1 week
  • Reduce dose by no more than 300mg every 3-7 days
  • Longer taper (2-4 weeks) if on high doses or long duration
  • Withdrawal symptoms may include: anxiety, insomnia, nausea, sweating, pain
  • Abrupt discontinuation in epilepsy may precipitate seizures

๐Ÿ’Š Drug Interactions

  • Opioids: Increased respiratory depression risk - use lowest effective doses
  • Alcohol: Enhanced CNS depression - avoid or limit
  • Antacids: Reduce gabapentin absorption by 20% - separate by 2 hours
  • Morphine: May increase gabapentin levels by 44%

๐Ÿ”„ Gabapentin โ†” Pregabalin Conversion

Approximate conversion: Gabapentin 300mg โ‰ˆ Pregabalin 50mg
Current dose equivalent: Gabapentin 1800mg โ‰ˆ Pregabalin ~300mg/day

Gabapentin DailyPregabalin DailyNotes
300-600mg50-100mgLow dose
900-1200mg150-200mgModerate dose
1800-2400mg300-400mgHigh dose
3600mg600mgMaximum dose

* Pregabalin has linear pharmacokinetics and better bioavailability than gabapentin

โšก Common Side Effects & Management

CNS Effects (most common)

  • Dizziness (20-30%): Usually improves, slower titration helps
  • Somnolence (15-25%): Take largest dose at bedtime
  • Ataxia (5-15%): Fall risk in elderly, reduce dose if severe
  • Fatigue (10%): May decrease over time
  • Cognitive effects: Memory, concentration issues

Other Effects

  • Peripheral edema (5-10%): Monitor weight, may need dose reduction
  • Weight gain (2-5%): More common at higher doses
  • Visual disturbances: Diplopia, blurred vision
  • GI upset: Nausea, diarrhea
  • Skin rash: Rare, discontinue if severe

๐Ÿ’ฌ Patient Counseling Points

Medication Instructions
  • Take with or without food (food may reduce GI upset)
  • Space doses evenly throughout the day (TID dosing)
  • Do not skip doses - maintain consistent schedule
  • If a dose is missed, take it as soon as remembered unless close to next dose
  • Swallow capsules whole or sprinkle on applesauce
  • Oral solution can be refrigerated but not required
Safety Warnings
  • โš ๏ธ Do NOT stop suddenly - must taper to prevent withdrawal/seizures
  • Avoid alcohol - increases sedation and dizziness
  • May impair driving and operating machinery
  • Report any mood changes, depression, or suicidal thoughts immediately
  • Tell all healthcare providers you take gabapentin
  • Do not share medication - Schedule V controlled substance
When to Seek Medical Attention
  • Difficulty breathing or shortness of breath
  • Severe dizziness or fainting
  • Severe skin rash or allergic reaction
  • Unusual mood or behavior changes
  • Thoughts of self-harm or suicide
  • Signs of muscle breakdown (severe muscle pain, weakness, dark urine)
  • Worsening seizures (for epilepsy patients)

๐Ÿ“‹ Recommended Monitoring

  • Assess pain/seizure control regularly
  • Monitor for CNS effects (sedation, dizziness, ataxia)
  • Check for peripheral edema
  • Monitor renal function if impaired

Additional monitoring considerations:

  • Weight at baseline and periodically (for peripheral edema, weight gain)
  • Renal function (creatinine, eGFR) if impaired at baseline
  • Fall risk assessment in elderly patients
  • Psychiatric evaluation if history of depression
  • Pain/seizure control efficacy assessment

๐Ÿ‘ฅ Special Populations

Elderly (โ‰ฅ65 years)

  • Start low (100-300mg/day)
  • Titrate slowly
  • Increased fall risk
  • Monitor renal function

Pediatric (3-12 years)

  • Epilepsy: 10-15 mg/kg/day
  • Increase over 3 days
  • Max: 35-50 mg/kg/day
  • Not for neuropathic pain

Pregnancy

  • Category C
  • Use if benefit > risk
  • Registry: 888-233-2334
  • Monitor newborn if used near delivery

๐Ÿ’ก Clinical Pearls

  • Peak efficacy for neuropathic pain may take 4-8 weeks - set realistic expectations
  • TID dosing is preferred due to saturable absorption - BID/QD less effective
  • Taking with food increases absorption by ~10% and may reduce GI upset
  • Gabapentin enacarbil (Horizant) is a prodrug with improved bioavailability for RLS
  • If switching to pregabalin, consider 1-week overlap/cross-taper
  • Effective for hot flashes (off-label) at 900mg/day
  • May reduce opioid requirements in multimodal pain management

FDA Safety Information

BOXED WARNING (2019): Gabapentinoids (gabapentin, pregabalin) can cause serious, life-threatening respiratory depression when used with opioids or in patients with respiratory conditions including COPD, sleep apnea, and in elderly patients. This medication is a Schedule V controlled substance with potential for abuse and diversion. Physical dependence can occur - do not stop abruptly; taper over at least 1 week. Monitor for signs of respiratory depression especially during initiation and dose increases. This calculator is for educational purposes only and does not replace clinical judgment.

For informational purposes only โ€” not medical advice. Consult a healthcare professional before acting on results.

๐Ÿฅ Health Facts

โš ๏ธ

Boxed warning: respiratory depression with CNS depressants

โ€” FDA 2019

What is Gabapentin?

Gabapentin (Neurontin, Gralise, Horizant) is a GABA analog anticonvulsant primarily used for neuropathic pain and as adjunctive therapy for partial seizures. Despite its name, it does not bind to GABA receptors but instead modulates voltage-gated calcium channels containing the ฮฑ2ฮด-1 subunit.

FDA Boxed Warning (2019)

Serious, life-threatening, and fatal respiratory depression can occur when gabapentinoids are co-administered with CNS depressants including opioids, or in patients with underlying respiratory impairment.

FDA-Approved Uses

  • โ€ข Postherpetic neuralgia
  • โ€ข Partial seizures (adjunct)
  • โ€ข Restless legs syndrome (Horizant)

Common Off-Label Uses

  • โ€ข Diabetic neuropathy
  • โ€ข Fibromyalgia
  • โ€ข Anxiety disorders
  • โ€ข Migraine prophylaxis

Key Safety Points

  • โ€ข Respiratory depression with opioids
  • โ€ข Renal dose adjustment required
  • โ€ข Taper to discontinue
  • โ€ข Schedule V controlled substance

Renal Dosing Guidelines

CrCl (mL/min)Max Daily DoseFrequencyNotes
60-โˆž3600mgTIDStandard dosing
30-591400mgBIDModerate impairment - 50% reduction
15-29700mgQDSevere impairment - 75% reduction
<15300mgQODESRD - give post-HD if on dialysis
๐Ÿ‘ˆ START HERE
โฌ…๏ธJump in and explore the concept!
AI

Related Calculators